Feymer(SH:688350)2022-04-28 16:00Financial Performance - The company's operating revenue for Q1 2022 was CNY 377,916,101.28, representing a year-over-year increase of 20.62%[5] - The net profit attributable to shareholders decreased by 18.72% to CNY 27,852,502.07[5] - The net profit after deducting non-recurring gains and losses was CNY 23,896,732.20, down by 11.89% compared to the same period last year[5] - Basic earnings per share were CNY 0.23, a decrease of 25.81% year-over-year[6] - Net profit for Q1 2022 was CNY 27,852,502.07, compared to CNY 34,264,351.60 in Q1 2021, reflecting a decrease of approximately 18.6%[24] - Earnings per share for Q1 2022 were CNY 0.23, down from CNY 0.31 in Q1 2021, a decline of about 25.8%[24] - The company's net profit for Q1 2022 was CNY 28,186,193.36, a decrease of 9.1% compared to CNY 31,331,348.46 in Q1 2021[35] - The total profit for Q1 2022 was CNY 31,210,587.28, down from CNY 35,749,919.80 in Q1 2021, representing a decline of 12.7%[35] Cash Flow - The net cash flow from operating activities increased significantly by 355.46% to CNY 16,094,073.39[5] - Cash flow from operating activities increased to CNY 10,830,285.70 in Q1 2022, compared to CNY 8,904,170.77 in Q1 2021, representing a growth of 21.6%[37] - Net cash flow from investing activities for Q1 2022 was negative CNY 35,055,246.21, compared to negative CNY 258,784,789.42 in Q1 2021, indicating an improvement[29] - The company reported a net cash outflow from investing activities of CNY 14,647,912.65 in Q1 2022, an improvement from a net outflow of CNY 257,369,016.34 in Q1 2021[38] - The company reported a net cash outflow from financing activities of negative CNY 4,246,977.85 in Q1 2022, a decrease from a net inflow of CNY 386,598,073.65 in Q1 2021[29] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,841,127,365.77, a decrease of 0.37% from the end of the previous year[6] - The total assets as of Q1 2022 were CNY 1,841,127,365.77, slightly down from CNY 1,847,893,883.47 at the end of the previous period[19] - Total current assets as of March 31, 2022, amounted to ¥1,186,132,798.24, a decrease from ¥1,205,084,185.89 as of December 31, 2021, reflecting a decline of approximately 1.5%[17] - Total liabilities for Q1 2022 were CNY 429,583,332.93, a decrease from CNY 453,608,361.38 in the previous period, showing a reduction of approximately 5.3%[19] - Total liabilities decreased to CNY 357,795,727.93 as of March 31, 2022, from CNY 383,077,399.64 as of December 31, 2021[33] Research and Development - Research and development expenses totaled CNY 16,694,187.09, accounting for 4.42% of operating revenue, an increase of 0.23 percentage points[6] - Research and development expenses for Q1 2022 were CNY 16,694,187.09, up from CNY 13,112,243.46 in Q1 2021, reflecting an increase of approximately 27.5%[23] - Research and development expenses rose significantly to CNY 12,192,323.91 in Q1 2022, compared to CNY 8,413,932.73 in Q1 2021, marking an increase of 44.5%[35] Shareholder Information - The company reported a total of 10,860,977 shares held by Beijing Ruishi Bang Fine Chemical Technology Co., Ltd., representing 8.89% of total shares[14] - The top ten shareholders collectively hold significant stakes, with the largest shareholder owning 10,860,977 shares, indicating a concentrated ownership structure[14] Other Information - The company has not disclosed any new product developments or technological advancements during this reporting period[15] - There are no significant mergers or acquisitions reported in the current quarter[15] - The company has not provided specific future guidance or performance outlook for the upcoming quarters[15] - No significant changes in the management or operational strategies were noted in the report[15]